Previous 10 | Next 10 |
ANN ARBOR, Mich., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that President and Chief Executive Officer, Sheldon Koenig, will present at the upcoming virtual J.P. Morgan 40 th Annual Healthcare Conference on Thursday, January 13, 2022 at 10:30 a.m. Eastern...
Intercontinental Exchange will add 138 securities to the ICE Biotechnology index and delete 26 as part of the annual reconstitution, effective prior to market open on December 20. Notable additions: Aurinia Pharmaceuticals (NASDAQ:AUPH), Anavex Life Sciences (NASDAQ:AVXL), Sesen Bio...
An increasing focus on integrating advanced technologies into research efforts to generate viable drugs for treating various critical ailments, and growing demand for therapies from an aging population, should boost the biotech industry's growth. Given this backdrop, Wall Street analysts expe...
ANN ARBOR, Mich., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) (“Esperion” or the “Company”), today announced the closing of its previously announced underwritten public offering of 32,142,858 shares of its common stock and accompanying warrants...
Friday's midday trading saw Zillow (NASDAQ:Z)(NASDAQ:ZG) recover a portion of the losses it suffered after its sudden decision recently to close down its home-flipping business. The stock gained after the company revealed progress in winding down the inventory of homes it stockpiled during th...
Gainers: Celyad (NASDAQ:CYAD) +35%. Longeveron (NASDAQ:LGVN) +29%. Marvell Technology (NASDAQ:MRVL) +18%. Petros Pharmaceuticals (NASDAQ:PTPI) +17%. CTI BioPharma (NASDAQ:CTIC) +16%. Tilly's (NYSE:TLYS) +14%. Krispy Kreme (NASDAQ:DNUT) +10%. PetIQ (NASDAQ:PETQ) +9%. Vicinity (NASDAQ:VEV) +9%....
Gainers: Celyad Oncology CYAD +41%, Longeveron LGVN +28%, Petros Pharmaceuticals (NASDAQ:PTPI) +26%, AirSculpt Technologies AIRS +12%, Werewolf Therapeutics (NASDAQ:HOWL) +12%. Losers: Esperion Therapeutics ESPR -40%, Biofrontera (NASDAQ:...
Esperion (NASDAQ:ESPR) has priced its public offering of ~32.1M shares of common stock and short-term warrants to purchase up to equal number of shares. Each common share is being sold together with one warrant at a combined price of $7.00/share, for expected gross proceeds of ~$225M. Underwr...
ANN ARBOR, Mich., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) (“Esperion” or the “Company”), today announced the pricing of its previously announced underwritten public offering of 32,142,858 shares of its common stock and short-term warrants to pur...
Esperion (NASDAQ:ESPR) has slipped 13.15% in after-hours trading on announcing a proposed public offering of its common stock and warrants to purchase shares of common stock. Terms of the offering are yet to be determined. The underwriter may be granted a 30-day option to purchase a...
News, Short Squeeze, Breakout and More Instantly...
Esperion Therapeutics Inc. Company Name:
ESPR Stock Symbol:
NASDAQ Market:
Esperion Therapeutics Inc. Website:
ANN ARBOR, Mich., July 25, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report second quarter 2024 financial results before the market opens on Monday, August 12, 2024. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financi...
ANN ARBOR, Mich., July 24, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the BTIG Biotech Conference on Monday, August 5, 2024, at 4 p.m. ET. Esperion Therapeutics At Esperion, we discover, develop, and commercialize innovat...
– Targeted Campaign Reaches Patients at Risk for Heart Attack or Heart Procedures Because of High LDL Cholesterol (LDL-C) – – Animated Characters Are a Visual Representation of An Unseen Risk “Lurking” In Patients’ Artery Walls &...